Presentation Information
[O5-02E]Efficacy of monovalent and bivalent Lassa virus mRNA vaccines in a surrogate mouse model
*Mei Hashizume1, Keiko Shindo1,2, Ayako Takashima1, Igor S. Lukashevich3, Juan C. de la Torre4, Masaharu Iwasaki1,2,5,6 (1. Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. Center for Advanced Modalities and Drug Delivery System, The University of Osaka (Japan), 3. Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center (USA), 4. Department of Immunology and Microbiology, Scripps Research (USA), 5. Center for Infectious Disease Education and Research, The University of Osaka (Japan), 6. RNA Frontier Science Division, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan))
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
